Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
UK scientists uncover startling new link between HRT and Alzheimer's
Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
Hosted on MSN3h
Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Shropshire Star19h
World’s largest proteins study ‘invaluable’ for understanding disease – experts
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
New blood test reveals risk of developing different diseases in 'new frontier of science'
A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...
studyfinds1d
Finally, an accurate blood test for Alzheimer’s at its earliest stages could be on horizon
Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Florey Dementia Index: This online tool predicts age of onset for early Alzheimer’s disease
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...
Hosted on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...